Back to search

Article

Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese study

2024-03-25

Abstract excerpt

ntroduction: Non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutations forms a distinct subgroup. The optimal management for uncommon EGFR mutant locally advanced NSCLC remains uncertain. This study aims to investigate the clinical features and outcomes. <h4>Methods:</h4> A multi-center retrospective study was conducted to review 511 patients with EGFR mutant unresectable stage III...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1585456f-09ca-5d3b-88e8-f3573a187f8b
DOI
10.21203/rs.3.rs-4130244/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Clinical features and outcomes of unresectable locally advanced non-small cell lung cancer with uncommon EGFR Mutations: A retrospective multi-center Chinese studyDOI 10.21203/rs.3.rs-4130244/v1
Uncommon mutation types of epidermal growth factor receptor and response to EGFR tyrosine kinase inhibitors in Chinese non-small cell lung cancer patients.Semantic proximity
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer.Semantic proximity
EGFR tyrosine kinase inhibitor (TKI) in patients with advanced non-small cell lung cancer (NSCLC) harboring uncommon EGFR mutations: A real-world study in China.Semantic proximity
Effectiveness of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients with uncommon EGFR mutations: A multicenter observational study.Semantic proximity
Efficacy of EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients harboring different types of EGFR mutations: A retrospective analysis.Semantic proximity
Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysisSemantic proximity
Treatment of uncommon EGFR mutations in non-small cell lung cancer: new evidence and treatmentSemantic proximity
Clinical features and treatment outcome of non-small cell lung cancer (NSCLC) patients with uncommon or complex epidermal growth factor receptor (EGFR) mutations.Semantic proximity
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need.Semantic proximity
Pathological Signature and Therapeutic Status of NSCLC Patients with Common or Rare Driver Gene Alterations in North China：A real world retrospective studySemantic proximity
Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical NeedSemantic proximity
[Effectiveness of Tyrosine Kinase Inhibitors on Uncommon Epidermal Growth Factor Receptor Mutations in Non-small Cell Lung Cancer].Semantic proximity
Select a neighboring publication to make it the new centre.